Antifungal Drugs - Global Market Outlook (2016-2022)

  • ID: 4428369
  • Report
  • Region: Global
  • 190 pages
  • Stratistics Market Research Consulting Pvt Ltd
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Bayer Healthcare
  • Enzon Pharmaceuticals
  • GlaxoSmithKline
  • Kramer Laboratories
  • Merck & Co. Inc.
  • MORE
“According to MRC, the Global Antifungal Drugs Market is accounted for $13.2 billion in 2016 and is expected to reach $18.2 billion by 2022 growing at a CAGR of 5.4% during the forecast period”. Factors such as rising government and corporate financial support in the industry, growing awareness of fungal infections and increase in disposable income are fueling the market growth. However, generic competition and huge diffusion of conventional drugs used for the treatment of fungal infections are hampering the market growth. Cost of drugs and their effectiveness in treatment are major challenges in the market.

Dermatophytosis segment is anticipated to hold the largest market share during the forecast period due to increasing prevalence of skin infections in children. Candidiasis segment is expected to grow at the highest CAGR during the forecast period. North America is anticipated to account for the largest market share owing to the huge patient awareness levels and increased R&D spending pertaining to new drug development. Asia Pacific is expected to grow at the highest CAGR during the forecast period owing to rising awareness towards personal safety and health care.

Some of the key players in Antifungal Drugs market include GlaxoSmithKline, Agilent Technologies, Inc., Kramer Laboratories, Bayer Healthcare, Abbott Laboratories, Novartis, Glenmark Pharmaceuticals Ltd, Merck & Co. Inc.,Pfizer Inc., Enzon Pharmaceuticals, PerkinElmer, Inc., Alternaria, Sigma-Aldrich and Astellas Pharma Inc.

Therapeutic Indications Covered:
  • Candidiasis
  • Dermatophytosis
  • Aspergillosis
  • Other Therapeutic Indications
Product Forms Covered:
  • Liquids or Spray
  • Shampoo
  • Gels
  • Injections
  • Tablets (Pill)
  • Cream
Types Covered:
  • Polyenes
  • Azoles
  • Imidazole
  • Thiazoles
  • Voricanazole
  • Triazole
  • Allylamines
  • Echinocandins
  • Other Drugs Types
Distribution Channels Covered:
  • Retail Pharmacies
  • Specialty Clinics
  • E-commerce
  • Hospital Pharmacies
Regions Covered:
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Italy
  • UK
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • Rest of Asia Pacific
  • Rest of the World
  • Middle East
  • Brazil
  • Argentina
  • South Africa
  • Egypt
What The Report Offers:
  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Bayer Healthcare
  • Enzon Pharmaceuticals
  • GlaxoSmithKline
  • Kramer Laboratories
  • Merck & Co. Inc.
  • MORE
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Antifungal Drugs Market, By Therapeutic Indication
5.1 Introduction
5.2 Candidiasis
5.3 Dermatophytosis
5.4 Aspergillosis
5.5 Other Therapeutic Indications

6 Global Antifungal Drugs Market, By Product Form
6.1 Introduction
6.2 Liquids or Spray
6.3 Shampoo
6.4 Gels
6.5 Injections
6.6 Tablets (Pill)
6.7 Cream

7 Global Antifungal Drugs Market, By Drugs Type
7.1 Introduction
7.2 Polyenes
7.3 Azoles
7.3.1 Imidazole
7.3.2 Thiazoles
7.3.3 Voricanazole
7.3.4 Triazole
7.4 Allylamines
7.5 Echinocandins
7.6 Other Drugs Types

8 Global Antifungal Drugs Market, By Distribution Channel
8.1 Introduction
8.2 Retail Pharmacies
8.3 Specialty Clinics
8.4 E-commerce
8.5 Hospital Pharmacies

9 Global Antifungal Drugs Market, By Geography
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 GlaxoSmithKline
11.2 Agilent Technologies, Inc.
11.3 Kramer Laboratories
11.4 Bayer Healthcare
11.5 Abbott Laboratories
11.6 Novartis
11.7 Glenmark Pharmaceuticals Ltd
11.8 Merck & Co. Inc.
11.9 Pfizer Inc.
11.10 Enzon Pharmaceuticals
11.11 PerkinElmer, Inc.,
11.12 Alternaria
11.13 Sigma-Aldrich
11.14 Astellas Pharma Inc

List of Tables

Table 1 Global Antifungal Drugs Market Outlook, By Region (2014-2022) ($MN)
Table 2 Global Antifungal Drugs Market Outlook, By Therapeutic Indication (2014-2022) ($MN)
Table 3 Global Antifungal Drugs Market Outlook, By Candidiasis (2014-2022) ($MN)
Table 4 Global Antifungal Drugs Market Outlook, By Dermatophytosis (2014-2022) ($MN)
Table 5 Global Antifungal Drugs Market Outlook, By Aspergillosis (2014-2022) ($MN)
Table 6 Global Antifungal Drugs Market Outlook, By Other Therapeutic Indications (2014-2022) ($MN)
Table 7 Global Antifungal Drugs Market Outlook, By Product Form (2014-2022) ($MN)
Table 8 Global Antifungal Drugs Market Outlook, By Liquids or Spray (2014-2022) ($MN)
Table 9 Global Antifungal Drugs Market Outlook, By Shampoo (2014-2022) ($MN)
Table 10 Global Antifungal Drugs Market Outlook, By Gels (2014-2022) ($MN)
Table 11 Global Antifungal Drugs Market Outlook, By Injections (2014-2022) ($MN)
Table 12 Global Antifungal Drugs Market Outlook, By Tablets (Pill) (2014-2022) ($MN)
Table 13 Global Antifungal Drugs Market Outlook, By Cream (2014-2022) ($MN)
Table 14 Global Antifungal Drugs Market Outlook, By Drugs Type (2014-2022) ($MN)
Table 15 Global Antifungal Drugs Market Outlook, By Polyenes (2014-2022) ($MN)
Table 16 Global Antifungal Drugs Market Outlook, By Azoles (2014-2022) ($MN)
Table 17 Global Antifungal Drugs Market Outlook, By Imidazole (2014-2022) ($MN)
Table 18 Global Antifungal Drugs Market Outlook, By Thiazoles (2014-2022) ($MN)
Table 19 Global Antifungal Drugs Market Outlook, By Voricanazole (2014-2022) ($MN)
Table 20 Global Antifungal Drugs Market Outlook, By Triazole (2014-2022) ($MN)
Table 21 Global Antifungal Drugs Market Outlook, By Allylamines (2014-2022) ($MN)
Table 22 Global Antifungal Drugs Market Outlook, By Echinocandins (2014-2022) ($MN)
Table 23 Global Antifungal Drugs Market Outlook, By Other Drugs Types (2014-2022) ($MN)
Table 24 Global Antifungal Drugs Market Outlook, By Distribution Channel (2014-2022) ($MN)
Table 25 Global Antifungal Drugs Market Outlook, By Retail Pharmacies (2014-2022) ($MN)
Table 26 Global Antifungal Drugs Market Outlook, By Specialty Clinics (2014-2022) ($MN)
Table 27 Global Antifungal Drugs Market Outlook, By E-commerce (2014-2022) ($MN)
Table 28 Global Antifungal Drugs Market Outlook, By Hospital Pharmacies (2014-2022) ($MN)
Table 29 North America Antifungal Drugs Market Outlook, By Country (2014-2022) ($MN)
Table 30 North America Antifungal Drugs Market Outlook, By Therapeutic Indication (2014-2022) ($MN)
Table 31 North America Antifungal Drugs Market Outlook, By Candidiasis (2014-2022) ($MN)
Table 32 North America Antifungal Drugs Market Outlook, By Dermatophytosis (2014-2022) ($MN)
Table 33 North America Antifungal Drugs Market Outlook, By Aspergillosis (2014-2022) ($MN)
Table 34 North America Antifungal Drugs Market Outlook, By Other Therapeutic Indications (2014-2022) ($MN)
Table 35 North America Antifungal Drugs Market Outlook, By Product Form (2014-2022) ($MN)
Table 36 North America Antifungal Drugs Market Outlook, By Liquids or Spray (2014-2022) ($MN)
Table 37 North America Antifungal Drugs Market Outlook, By Shampoo (2014-2022) ($MN)
Table 38 North America Antifungal Drugs Market Outlook, By Gels (2014-2022) ($MN)
Table 39 North America Antifungal Drugs Market Outlook, By Injections (2014-2022) ($MN)
Table 40 North America Antifungal Drugs Market Outlook, By Tablets (Pill) (2014-2022) ($MN)
Table 41 North America Antifungal Drugs Market Outlook, By Cream (2014-2022) ($MN)
Table 42 North America Antifungal Drugs Market Outlook, By Drugs Type (2014-2022) ($MN)
Table 43 North America Antifungal Drugs Market Outlook, By Polyenes (2014-2022) ($MN)
Table 44 North America Antifungal Drugs Market Outlook, By Azoles (2014-2022) ($MN)
Table 45 North America Antifungal Drugs Market Outlook, By Imidazole (2014-2022) ($MN)
Table 46 North America Antifungal Drugs Market Outlook, By Thiazoles (2014-2022) ($MN)
Table 47 North America Antifungal Drugs Market Outlook, By Voricanazole (2014-2022) ($MN)
Table 48 North America Antifungal Drugs Market Outlook, By Triazole (2014-2022) ($MN)
Table 49 North America Antifungal Drugs Market Outlook, By Allylamines (2014-2022) ($MN)
Table 50 North America Antifungal Drugs Market Outlook, By Echinocandins (2014-2022) ($MN)
Table 51 North America Antifungal Drugs Market Outlook, By Other Drugs Types (2014-2022) ($MN)
Table 52 North America Antifungal Drugs Market Outlook, By Distribution Channel (2014-2022) ($MN)
Table 53 North America Antifungal Drugs Market Outlook, By Retail Pharmacies (2014-2022) ($MN)
Table 54 North America Antifungal Drugs Market Outlook, By Specialty Clinics (2014-2022) ($MN)
Table 55 North America Antifungal Drugs Market Outlook, By E-commerce (2014-2022) ($MN)
Table 56 North America Antifungal Drugs Market Outlook, By Hospital Pharmacies (2014-2022) ($MN)
Table 57 Europe Antifungal Drugs Market Outlook, By Country (2014-2022) ($MN)
Table 58 Europe Antifungal Drugs Market Outlook, By Therapeutic Indication (2014-2022) ($MN)
Table 59 Europe Antifungal Drugs Market Outlook, By Candidiasis (2014-2022) ($MN)
Table 60 Europe Antifungal Drugs Market Outlook, By Dermatophytosis (2014-2022) ($MN)
Table 61 Europe Antifungal Drugs Market Outlook, By Aspergillosis (2014-2022) ($MN)
Table 62 Europe Antifungal Drugs Market Outlook, By Other Therapeutic Indications (2014-2022) ($MN)
Table 63 Europe Antifungal Drugs Market Outlook, By Product Form (2014-2022) ($MN)
Table 64 Europe Antifungal Drugs Market Outlook, By Liquids or Spray (2014-2022) ($MN)
Table 65 Europe Antifungal Drugs Market Outlook, By Shampoo (2014-2022) ($MN)
Table 66 Europe Antifungal Drugs Market Outlook, By Gels (2014-2022) ($MN)
Table 67 Europe Antifungal Drugs Market Outlook, By Injections (2014-2022) ($MN)
Table 68 Europe Antifungal Drugs Market Outlook, By Tablets (Pill) (2014-2022) ($MN)
Table 69 Europe Antifungal Drugs Market Outlook, By Cream (2014-2022) ($MN)
Table 70 Europe Antifungal Drugs Market Outlook, By Drugs Type (2014-2022) ($MN)
Table 71 Europe Antifungal Drugs Market Outlook, By Polyenes (2014-2022) ($MN)
Table 72 Europe Antifungal Drugs Market Outlook, By Azoles (2014-2022) ($MN)
Table 73 Europe Antifungal Drugs Market Outlook, By Imidazole (2014-2022) ($MN)
Table 74 Europe Antifungal Drugs Market Outlook, By Thiazoles (2014-2022) ($MN)
Table 75 Europe Antifungal Drugs Market Outlook, By Voricanazole (2014-2022) ($MN)
Table 76 Europe Antifungal Drugs Market Outlook, By Triazole (2014-2022) ($MN)
Table 77 Europe Antifungal Drugs Market Outlook, By Allylamines (2014-2022) ($MN)
Table 78 Europe Antifungal Drugs Market Outlook, By Echinocandins (2014-2022) ($MN)
Table 79 Europe Antifungal Drugs Market Outlook, By Other Drugs Types (2014-2022) ($MN)
Table 80 Europe Antifungal Drugs Market Outlook, By Distribution Channel (2014-2022) ($MN)
Table 81 Europe Antifungal Drugs Market Outlook, By Retail Pharmacies (2014-2022) ($MN)
Table 82 Europe Antifungal Drugs Market Outlook, By Specialty Clinics (2014-2022) ($MN)
Table 83 Europe Antifungal Drugs Market Outlook, By E-commerce (2014-2022) ($MN)
Table 84 Europe Antifungal Drugs Market Outlook, By Hospital Pharmacies (2014-2022) ($MN)
Table 85 Asia Pacific Antifungal Drugs Market Outlook, By Country (2014-2022) ($MN)
Table 86 Asia Pacific Antifungal Drugs Market Outlook, By Therapeutic Indication (2014-2022) ($MN)
Table 87 Asia Pacific Antifungal Drugs Market Outlook, By Candidiasis (2014-2022) ($MN)
Table 88 Asia Pacific Antifungal Drugs Market Outlook, By Dermatophytosis (2014-2022) ($MN)
Table 89 Asia Pacific Antifungal Drugs Market Outlook, By Aspergillosis (2014-2022) ($MN)
Table 90 Asia Pacific Antifungal Drugs Market Outlook, By Other Therapeutic Indications (2014-2022) ($MN)
Table 91 Asia Pacific Antifungal Drugs Market Outlook, By Product Form (2014-2022) ($MN)
Table 92 Asia Pacific Antifungal Drugs Market Outlook, By Liquids or Spray (2014-2022) ($MN)
Table 93 Asia Pacific Antifungal Drugs Market Outlook, By Shampoo (2014-2022) ($MN)
Table 94 Asia Pacific Antifungal Drugs Market Outlook, By Gels (2014-2022) ($MN)
Table 95 Asia Pacific Antifungal Drugs Market Outlook, By Injections (2014-2022) ($MN)
Table 96 Asia Pacific Antifungal Drugs Market Outlook, By Tablets (Pill) (2014-2022) ($MN)
Table 97 Asia Pacific Antifungal Drugs Market Outlook, By Cream (2014-2022) ($MN)
Table 98 Asia Pacific Antifungal Drugs Market Outlook, By Drugs Type (2014-2022) ($MN)
Table 99 Asia Pacific Antifungal Drugs Market Outlook, By Polyenes (2014-2022) ($MN)
Table 100 Asia Pacific Antifungal Drugs Market Outlook, By Azoles (2014-2022) ($MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • GlaxoSmithKline
  • Agilent Technologies, Inc.
  • Kramer Laboratories
  • Bayer Healthcare
  • Abbott Laboratories
  • Novartis
  • Glenmark Pharmaceuticals Ltd
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Enzon Pharmaceuticals
  • PerkinElmer, Inc.,
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll